Be part of the organisation putting ideas to work.

Career opportunities at the University of Manchester Innovation Factory:

Opportunities to contribute to early stage business ventures

Are you an expert or a professional with experience in scientific, engineering, or MedTech/Pharma companies? Do you have a proven track record of leadership in a commercial role?  We are dedicated to helping UoM’s spinouts attract the best and most experienced talent.

We invite you to submit your CV to be considered for future opportunities with our innovative new spinout companies. With your permission, we will keep your CV ready for the next opening in one of our spinouts which may interest you.

Help us build a community of talented individuals ready to drive innovation forward. Submit your CV today to talent@uominnovationfactory.com and be part of the future of Manchester’s innovative spinouts.  

Lutèo Medical launches to advance microbiome-based healthcare innovation

Lutèo Medical, a new biotechnology company developing microbiome-based healthcare solutions, has launched as a spinout company from The University of Manchester. The company is focused on translating cutting-edge microbiome science into innovative technologies designed to tackle major healthcare challenges and improve patient outcomes.

University of Manchester spinouts showcased at London Tech Week

Four spinouts emerging from the University of Manchester are set to showcase their technologies at London Tech Week as part of Northern Gritstone’s NG Studios programme, culminating in a key Demo Day for investors and industry partners at Olympia London on 9 June.

Impact of Shared Technology Transfer Office Pilot Programme

The University of Manchester Innovation Factory has welcomed the publication of the UK Research and Innovation (UKRI) Research England evaluation of the Shared Technology Transfer Office (TTO) Pilot Programme, which explored new collaborative approaches to university commercialisation and innovation support.

Imperagen secures £5 million investment

Imperagen, a Manchester-based techbio company using AI and quantum physics to engineer better enzymes faster, has closed a £5 million seed funding round led by PXN Ventures with participation from Imperagen’s existing investors IQ Capital and Northern Gritstone.